Intramuscular and intravenous sedation.
Conditions
Interventions
Intervention 1: Intervention group: Intramuscular injection:Drugs used in the intramuscular group include the combination of 6 mg/kg of ketamine (500 mg/10 ml, EXIR, Iran), 0.05 mg/kg of midazolam (0.
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 6 Years
Inclusion criteria
Inclusion criteria: Uncooperative 2–6-year-old children with definitely negative or negative Frankl scores, who were referred to the Pediatric Dentistry Fellowship Clinic at the Dental School of Shahid Beheshti University of Medical Sciences, Tehran, Iran, and required at least 2 similar dental treatment visits.The subjects were included if they were classified as ASA I, according to the American Society of Anesthesiology (ASA).
Exclusion criteria
Exclusion criteria: Children with nasal obstruction, respiratory infections, limitations in neck movement, macroglossia, tonsil hypertrophy, micrognathia, or limitations in mouth opening were excluded.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Physiological parameters. Timepoint: T0: the beginning of work; T1: after anesthesia injection; T2: 15 minutes after starting work, T3: 30 minutes after starting work and T4: end of work. Method of measurement: Data table. | — |
Primary
| Measure | Time frame |
|---|---|
| The level of sedation and behavioral evaluation based on the Houpt criterion. Timepoint: T0: the beginning of work; T1: after anesthesia injection; T2: 15 minutes after starting work, T3: 30 minutes after starting work and T4: end of work. Method of measurement: Houpt Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLeila Eftekhar
Shahid Beheshti University of Medical Sciences
Outcome results
None listed